Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 525

1.

Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients.

Blin O, Azorin JM, Bouhours P.

J Clin Psychopharmacol. 1996 Feb;16(1):38-44.

PMID:
8834417
2.
3.

Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia.

Lindström E, Eriksson B, Hellgren A, von Knorring L, Eberhard G.

Clin Ther. 1995 May-Jun;17(3):402-12.

PMID:
7585844
4.

The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

Marder SR, Davis JM, Chouinard G.

J Clin Psychiatry. 1997 Dec;58(12):538-46. Erratum in: J Clin Psychiatry 1998 Apr;59(4):200.

PMID:
9448657
5.

Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

Int Clin Psychopharmacol. 2001 Nov;16(6):325-30.

PMID:
11712620
6.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
7.

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.

Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.

J Clin Psychopharmacol. 1993 Feb;13(1):25-40. Erratum in: J Clin Psychopharmacol 1993 Apr;13(2):149.

PMID:
7683702
9.

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia..

J Clin Psychiatry. 2007 Nov;68(11):1763-74.

PMID:
18052570
10.

Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel RR, Kleindienst N, Müller N, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):360-70. Epub 2007 Jul 14.

PMID:
17629731
11.

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.

Fleischhacker WW, Eerdekens M, Karcher K, Remington G, Llorca PM, Chrzanowski W, Martin S, Gefvert O.

J Clin Psychiatry. 2003 Oct;64(10):1250-7.

PMID:
14658976
12.

Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome.

Müller-Siecheneder F, Müller MJ, Hillert A, Szegedi A, Wetzel H, Benkert O.

J Clin Psychopharmacol. 1998 Apr;18(2):111-20.

PMID:
9555596
13.
14.
15.

Extrapyramidal symptoms in patients treated with risperidone.

Simpson GM, Lindenmayer JP.

J Clin Psychopharmacol. 1997 Jun;17(3):194-201.

PMID:
9169965
16.

A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.

Janicak PG, Keck PE Jr, Davis JM, Kasckow JW, Tugrul K, Dowd SM, Strong J, Sharma RP, Strakowski SM.

J Clin Psychopharmacol. 2001 Aug;21(4):360-8.

PMID:
11476119
17.

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.

Goff DC, Posever T, Herz L, Simmons J, Kletti N, Lapierre K, Wilner KD, Law CG, Ko GN.

J Clin Psychopharmacol. 1998 Aug;18(4):296-304.

PMID:
9690695
18.

Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.

Ouyang WC, Hsu MC, Yeh IN, Kuo CC.

Int J Psychiatry Clin Pract. 2012 Sep;16(3):178-88. doi: 10.3109/13651501.2011.644564. Epub 2012 Mar 9.

PMID:
22404731
20.

Risperidone in the treatment of schizophrenia: results of a study of patients from Germany, Austria, and Switzerland.

Möller HJ, Bäuml J, Ferrero F, Fuger J, Geretsegger C, Kasper S, Kissling W, Schubert H.

Eur Arch Psychiatry Clin Neurosci. 1997;247(6):291-6.

PMID:
9477007

Supplemental Content

Support Center